More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1·DRD is a growing epidemic ...

NEW YORK – Researchers have identified a gene signature that can predict whether early-stage breast cancer patients will respond to neoadjuvant treatment with anti-fibrotic therapies, such as ...

Give us Liberty! And ticker tape. The New York Liberty will become the first New York City women’s sports team to parade through the Canyon of Heroes if they win the WNBA finals, said Mayor Adams.

This new ticker symbol will replace the Company’s previous ticker symbol “TCJH”. No action by the Company’s shareholders is required with respect to the ticker symbol change. The Company's ...

There's been a cloud looming over Justin Fields's time as the Pittsburgh Steelers starting quarterback this season—the inevitable return of Russell Wilson. Ahead of the 2024 season, Steelers ...

Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the oncology-focused platform company’s decision to file for bankruptcy. Notable's ...

Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...

Boehringer Ingelheim partners with the WHO Foundation to financially support WHO’s Fourteenth General Programme of Work (2025 to 2028). Credit: PeopleImages.com – Yuri A/Shutterstock. Boehringer ...

In the video, Jackson intones the entire quote: “The path of the righteous man is beset on all sides by the iniquities of the selfish and the tyranny of evil men. Blessed is he who, in the name ...

"We are excited to announce our new holding company name and stock symbol, marking another milestone in our ongoing transformation. Over the past six months, the Board of Directors and management ...

INGELHEIM, Germany & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Boehringer Ingelheim and Circle Pharma (Circle) announce a new research collaboration and license agreement with the shared goal ...